Advertisement

Meeting Coverage

SARS-CoV-2 Vaccine Efficacy in Multiple Sclerosis

SARS-CoV-2 induced Coronavirus Disease 19 (COVD-19), a highly transmissible and potentially lethal illness, became a global pandemic in early 2020. Several vaccinations against this virus have been developed, including 2 novel...

Read More

ACTRIMS 2022 Kenneth P. Johnson Memorial Lecture

This year’s Kenneth P. Johnson Memorial Lecturer is Ruth Ann Marrie, MD, PhD, FRCPC. ACTRIMS presents an annual lecture named in honor of the late Dr. Kenneth P. Johnson who founded the foundation. The lecture provides an...

Read More

What You Need to Know About ACTRIMS 2022

The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) hosted the seventh annual forum, February 24-26. This year’s forum was themed Biomarkers in MS.  Highlights of the forum include the Kenneth...

Read More

What you need to know about SGO 2022

The Society of Gynecologic Oncology (SGO) 2022 Annual Meeting on Women’s Cancer is a comprehensive forum for the subspecialty of gynecologic oncology. Because of the continuing pandemic, the annual meeting will be hybrid taking...

Read More

SGO 2022 Master Classes

Operate and Optimize: Enhancing Perioperative Quality, Safety, Experience and Outcomes Friday, March 18, 8:00 a.m. to 12:00 p.m. MST Moderators: Rebecca Stone, MD, MS, and Sean Dowdy, MD Rare but Revelatory: Clinical Updates and...

Read More

SGO 2022 Featured Speakers

J. Nwando Olayiwola, MD, MPH, FAAFP American Board of Obstetrics and Gynecology Guest Lecturer Friday, March 18, 2:15 p.m. – 3:00 p.m. MST Reshma Jagsi, MD, DPhil Gender Equity Session: Together We Stand, Divided We Fall...

Read More

SGO Conference Schedule

Friday, March 18th: 7:00 AM – 12:30 PM Debulk and Deliver: Hands-On Cytoreductive Surgery Lab 8:00 AM – 12:00 PM Master Class: Rare but Revelatory: Clinical Updates & Research Advancements in Uncommon Gynecologic...

Read More

Alarming Drop in Cancer Screenings Due to Pandemic

A significant drop in the screening, diagnosis and treatment of genitourinary cancers was observed during the early months of the COVID-19 pandemic. Hereafter, a progressive recovery was observed. Notably, the screening rate for...

Read More
Advertisement